An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies. One year earlier, in June 2021 ...

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...

Dementia is a loss of brain function that affects memory, thinking, judgment, behavior, and language. Alzheimer's disease is the most common type of dementia. While there's no cure for dementia, ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.

He died of Alzheimer’s in 2019, at the age of 66. “That’s old for our family,” Reiswig said. For years, Reiswig resisted finding out whether he carried the mutation, but he did get tested ...

You will also find information about genetic testing for dementia. Genes determine our traits, such as our eye colour and height. In some cases, they can also determine whether we develop a disease, ...

A new approach to Alzheimer's disease treatment could be on the horizon, inspired by a compound found in common herbs. Carnosic acid is found in rosemary and sage and is known for its antioxidant and ...

2.5 Muscle harvest, immunofluorescence staining and NMJ analyses The EDL and tibialis anterior (TA ... and mouse anti-synaptic vesicle glycoprotein 2 (SV2,DSHB Cat# SV2, RRID:AB_2315387) or mouse anti ...